[Federal Register Volume 72, Number 247 (Thursday, December 27, 2007)]
[Notices]
[Page 73359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-25053]



[[Page 73359]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 31, 2007, Innovacon, 
Inc., 4106 Sorrento Valley Boulevard, San Diego, California 92121, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphetamine (MDMA)     I
 (7405).
Heroin (9200)..............................  I
Cocaine (9041).............................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Levorphanol (9220).........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The company plans to utilize small quantities of controlled 
substances to produce drugs of abuse tests.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than February 25, 2008.

    Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-25053 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P